Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
10/2003
10/02/2003US20030187238 Comprises nucleotide sequences coding membrane proteins for use as antiproliferative/antitumor/antiinflammatory agents; drug screening
10/02/2003US20030187230 Chimeric humanized monoclonal antibody for treating tumors and inflammation
10/02/2003US20030187229 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/02/2003US20030187228 Chimeric humanized monoclonal antibody for treating tumors and inflammation
10/02/2003US20030187226 Process of high purity albumin production
10/02/2003US20030187224 Chimeric OPG polypeptides
10/02/2003US20030187218 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes by contacting blood with pro-polypeptides; cancer diagnosis
10/02/2003US20030187215 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes by contacting blood with pro-polypeptides; cancer diagnosis
10/02/2003US20030187214 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/02/2003US20030187212 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/02/2003US20030187206 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/02/2003US20030187200 Comprises nucleotide sequences coding kunitz-type protease inhibitor for treating reproductive, hemostatic and inflammatory disorders
10/02/2003US20030187197 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/02/2003US20030187196 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/02/2003US20030187195 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/02/2003US20030187194 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/02/2003US20030187193 Comprises nucleotide sequences coding membrane protein for use as antitumor/anticarcinogenic/antiinflammatory/antiproliferative agents
10/02/2003US20030187192 Comprises nucleotide sequences coding membrane protein for use as antitumor/anticarcinogenic/antiinflammatory/antiproliferative agents
10/02/2003US20030187191 Comprises nucleotide sequences coding membrane protein for use as antitumor/anticarcinogenic/antiinflammatory/antiproliferative agents
10/02/2003US20030187190 Comprises nucleotide sequences coding membrane protein for use as antitumor/anticarcinogenic/antiinflammatory/antiproliferative agents
10/02/2003US20030187189 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/02/2003US20030186889 Diagnostic and medicament for analysing the cell surface proteome of tumour and inflammatory cells and for treating tumorous and inflammatory diseases, preferably using a specific chemokine receptor analysis and the chemokine receptor-ligand interaction
10/02/2003US20030186888 Diastereo analog of peptide SPFK-amide with selective anti-microbial activity and a method thereof
10/02/2003US20030186881 Nucleotide sequences comprising complementary DNA codes for cyclin-dependent kinases, that control phosphorylation in cells, used in diagnosis and prophylaxis of diseases
10/02/2003US20030186866 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
10/02/2003US20030186856 Process for the isolation of pharmaceutical compound cyclosporin a from fungus fusarium nivale
10/02/2003US20030186848 Recombinant iron uptake proteins
10/02/2003US20030186422 Methods for the treatment of thrombosis
10/02/2003US20030186421 Comprises lipoprotein associated phospholipase A2 (Lp-PLA2) for diagnosing and treating atherosclerosis; enzyme inhibitors
10/02/2003US20030186419 Masp-3, a complement-fixing enzyme, and uses for it
10/02/2003US20030186408 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/02/2003US20030186407 Comprises membrane protein for use as antitumor/antiproliferative/antiinflammatory/anticarcinogenic agents
10/02/2003US20030186388 Method of producing fr901228
10/02/2003US20030186381 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/02/2003US20030186380 Methods for producing secreted polypeptides having L-asparaginase activity
10/02/2003US20030186378 Useful mutations of bacterial alkaline protease
10/02/2003US20030186374 Multimeric polypeptide plasmid for expression of complex heterologous proteins
10/02/2003US20030186370 Comprises nucleotide sequences coding nicotinic-acetylcholine receptor (5-ht3) for use in screening nematocides, insecticides and/or pesticides
10/02/2003US20030186367 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/02/2003US20030186366 For stimulating release of tumor necrosis factor and/or cellular differentiation of chondrocytes, endothelial cells or adipocytes by contacting blood with pro-polypeptide; cancer diagnosis and treatment
10/02/2003US20030186359 Genes encoding insect odorant receptors and uses thereof
10/02/2003US20030186358 Comprise nucleotide sequences coding membrane protein for use as antitumor, antiproliferative, anticarcinogenic or antiinflammatory agents
10/02/2003US20030186346 Process for producing protein decomposition product
10/02/2003US20030186343 Immunoglobulin which binds low density lipoprotein receptor for diagnosis, prevention or treatment of viral infections; viricides
10/02/2003US20030186333 Comprises nervous system polypeptide for diagnosis, prognosis, treatment and evaluation of neurodegenerative disorders
10/02/2003US20030186324 Sensory neuron receptors
10/02/2003US20030186319 Comprises nucleotide sequences coding membrane protein for use as antiinflammatory/antitumor/anticarcinogenic/ antiproliferative agents
10/02/2003US20030186318 Comprises nucleotide sequences coding membrane protein for use as antiinflammatory/antitumor/anticarcinogenic/ antiproliferative agents
10/02/2003US20030186316 Method for identifying optimal binding ligands to a receptor
10/02/2003US20030186308 Prostacyclin-stimulating factor-2
10/02/2003US20030186306 Nucleotide sequences coding interleukins for treating tumors, bone, nervous system, neovascularization and autoimmune disorders
10/02/2003US20030186290 Gene involved in CADASIL, method of diagnosis and therapeutic application
10/02/2003US20030186275 Using bacterial peptides to develop vaccine to protect against mycobacterium infections
10/02/2003US20030186269 Ssa-56 kda polypeptide and its fragments and polynucleotides encoding said polypeptides and therapeutic uses
10/02/2003US20030186261 Method of increasing complementarity in a heteroduplex
10/02/2003US20030186258 Comprises protease (KEX1) for processing fusion proteins containing peptides or proteins of industrial and/or therapeutic interest; biocatalysts
10/02/2003US20030186249 Comprises nucleotide sequences coding a thymocyte cyclic AMP regulated phosphoprotein (TARPP) for treating, diagnosing, monitoring, prognosticating or preventing nervous system disorders
10/02/2003US20030186232 Human and non-human primate homologues of Nkd protein, nucleic acid sequences encoding, and uses thereof
10/02/2003US20030186225 Comprises DNA sequences coding viral protein for use in developing vaccine which prevents porcine reproductive and respiratory syndrome viral infections
10/02/2003US20030186223 Modular recombinatorial display libraries
10/02/2003US20030185862 Fusion peptide of human type- I collagen derived peptide and Tat peptide, preparation therof, and skin anti-aging cosmetic composition comprising the same
10/02/2003US20030185849 React with convalescent phase antiserum from an E. canis-infected dog; useful in the development of vaccines and serodiagnostics
10/02/2003US20030185846 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/02/2003US20030185842 Heat shock protein-based vaccines and immunotherapies
10/02/2003US20030185833 Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus
10/02/2003US20030185832 Administering a targeting agent operatively attached to a therapeutic agent; the targeting agent recognizes and binds to a tumor-associated endothelial cell marker.
10/02/2003US20030185830 Compositions and methods for the therapy and diagnosis of prostate cancer
10/02/2003US20030185823 Arming of activated T cells with BiAbs increases the effective precursor frequency of CTL in the cancer patient.
10/02/2003US20030185821 Antibodies to interleukin-4 receptors and uses thereof
10/02/2003US20030185820 Protein belonging to the TNF superfamily involved in signal transduction, nucleic acids encoding same, and methods of use thereof
10/02/2003US20030185819 Treatment of specific and non-specific inflammation, including asthma; useful in diagnosing and localizing sites of inflammation.
10/02/2003US20030185818 Humanized antibody against cd18
10/02/2003US20030185815 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
10/02/2003US20030185800 Human interferon-epsilon: a type I interferon
10/02/2003US20030185790 Methods of ex-vivo expansion of hematopoeitic cells using multivariant IL-3 hematopoiesis chimera proteins
10/02/2003CA2480561A1 Method of proliferating human hepatocytes and method of obtaining human hepatocytes
10/02/2003CA2480559A1 Antibody recognizing proliferative human liver cells, proliferative human liver cells and functional human liver cells
10/02/2003CA2480099A1 Erbb3 based methods and compositions for treating neoplasms
10/02/2003CA2479732A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/02/2003CA2479730A1 Novel compositions and methods in cancer
10/02/2003CA2479587A1 Nucleic acid constructs and methods for producing altered seed oil compositions
10/02/2003CA2478839A1 Angiogenesis regulator genes, pharmaceutical preparations containing same and uses thereof
10/02/2003CA2478113A1 Modified promoter capable of functioning in a filamentous fungus
10/02/2003CA2478063A1 Lymphatic and blood endothelial cell genes
10/01/2003EP1348758A1 Host cells having improved cell survival properties and methods to generate such cells
10/01/2003EP1348715A2 CD19xCD3 specific polypeptides and uses thereof
10/01/2003EP1348036A2 Protection against mycobacterial infections
10/01/2003EP1348029A2 Materials and methods relating to protein aggregation in neurodegenerative disease
10/01/2003EP1348027A2 Gene disruption methodologies for drug target discovery
10/01/2003EP1348022A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
10/01/2003EP1347992A2 Polymorphic bone morphogenetic protein 2
10/01/2003EP1347770A2 Method of making a protein polymer and uses of the polymer
10/01/2003EP1347730A2 Recombinant anti-cd30 antibodies and uses thereof
10/01/2003EP1100830B1 Heterominibodies
10/01/2003EP0726946B1 METHOD FOR SIMULTANEOUS IDENTIFICATION OF DIFFERENTIALLY EXPRESSED mRNAs AND MEASUREMENT OF RELATIVE CONCENTRATIONS
10/01/2003EP0662087B1 Method for purifying retinal pigmented epithelium derived neurotrophic factor
10/01/2003EP0638172B1 Methods and compositions for monitoring cellular processing of beta-amyloid precursor protein
10/01/2003CN1446227A Novel fibroblast growth factor (FRF23) and method for use
10/01/2003CN1446094A Method for obtaining antigenic structures enhancing specific cross reactivity
10/01/2003CN1445243A Fab antibody of human resourced neutrality genetic engineering for anti human cytomegalo virus
1 ... 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 ... 1125